CD4+ T cells impair tumor growth through IL-3 and TNF-dependent vascular damage (opens in new tab)

Most cancer immunotherapy strategies are focused on direct tumor killing by immune cells, especially T lymphocytes. Clinical and conceptual limitations of these approaches create a need for additional strategies. We identified a tumor stroma–targeting ...